As of 2025-05-31, the Fair Value of ARCA Biopharma Inc (ABIO) is -0.13 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.40 USD, the upside of ARCA Biopharma Inc is -105.41%.
With the market price of 2.40 USD and our fair value calculation, ARCA Biopharma Inc (ABIO) is not a good investment. Investing in ABIO stocks now will result in a potential loss of 105.41%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -5.48 | -9.74 | -19.32 | -9.93 | -5.34 | -9.96 |
| YoY growth | 30.90% | -77.74% | -98.38% | 48.63% | 46.21% | -10.08% |
| Market Cap (mil) | 665.32 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | -10.08% |
| TTM earnings | -7.20 |